Work

Epacadostat plus pembrolizumab in patients with advanced melanoma and select solid tumors: Updated phase 1 results from ECHO-202/KEYNOTE-037

Year: 2016

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw379.06

Authors: T.C. Gangadhar, O. Hamid, D.C. Smith, T.M. Bauer, J.S. Wasser, A.J. Olszanski, J.J. Luke, A.S. Balmanoukian, D.R. Kaufman, Y. Zhao, J. Maleski, M.J. Jones, L. Leopold, T.F. Gajewski

Institutions: Abramson Cancer Center, University of Pennsylvania, Angeles Clinic and Research Institute, University of Michigan, Sarah Cannon, Tennessee Oncology, UConn Health, Fox Chase Cancer Center, University of Chicago, Merck & Co., Inc., Rahway, NJ, USA (United States), Incyte (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2589004473

FWCI: 7.882

Cites:

Cited by: 58

Related to: 10